{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:50:33Z","timestamp":1789426233080,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.revmed.2022.10.002","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T07:28:54Z","timestamp":1666682934000},"page":"12-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mise au point sur les n\u00e9oplasies endocriniennes multiples"],"prefix":"10.1016","volume":"44","author":[{"given":"M.","family":"Duval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Haissaguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2022.10.002_bib0115","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4\u00a0and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.revmed.2022.10.002_bib0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ando.2021.03.005","article-title":"New therapies for patients with multiple endocrine neoplasia type 1","volume":"82","author":"Geslot","year":"2021","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.revmed.2022.10.002_bib0125","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2265.2007.02934.x","article-title":"Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258\u00a0gene carriers","volume":"67","author":"Machens","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.revmed.2022.10.002_bib0130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1159\/000511791","article-title":"Multiple endocrine neoplasia type 1\u00a0and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the men1\u00a0syndrome - an international consensus statement","volume":"111","author":"Niederle","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.revmed.2022.10.002_bib0135","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0003-4266(19)30113-1","article-title":"La n\u00e9oplasie endocrinienne multiple de type 1: mise au point apr\u00e8s le congr\u00e8s de l\u2019ENETS 2019: multiple endocrine neoplasia type 1: development after the ENETS 2019\u00a0Congress","volume":"80","author":"Vialon","year":"2019","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.revmed.2022.10.002_bib0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0003-4266(06)72533-1","article-title":"Prise en charge de l\u2019hyperparathyro\u00efdie primaire asymptomatique Consensus d\u2019experts de la SFE","volume":"67","author":"Calzada-Nocaudie","year":"2006","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.revmed.2022.10.002_bib0145","unstructured":"Masson E. Chirurgie de l\u2019hyperparathyro\u00efdie et de son \u00e9ventuelle r\u00e9cidive dans le cadre des n\u00e9oplasies endocriniennes multiples de type 1 [Internet]. EM-Consulte. [cit\u00e9 4 juill 2022]. Disponible sur: https:\/\/www.em-consulte.com\/article\/19544\/chirurgie-de-l-hyperparathyroidie-et-de-son-eventu."},{"key":"10.1016\/j.revmed.2022.10.002_bib0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ando.2014.07.322","article-title":"R\u00e9cidive tardive d\u2019hyperparathyro\u00efdie primaire dans le cadre d\u2019une n\u00e9oplasie endocrinienne multiple de type 1","volume":"75","author":"Meftah","year":"2014","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.revmed.2022.10.002_bib0155","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00268-010-0605-2","article-title":"Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1","volume":"34","author":"Salmeron","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.revmed.2022.10.002_bib0160","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.lpm.2018.03.005","article-title":"Update on multiple endocrine neoplasia Type 1\u00a0and 2","volume":"47","author":"Al-Salameh","year":"2018","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2022.10.002_bib0165","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/js.2018-00087","article-title":"Diagnosing nonfunctional pancreatic NETs in MEN1: the evidence base","volume":"2","author":"van Treijen","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.revmed.2022.10.002_bib0170","doi-asserted-by":"crossref","unstructured":"Modlin IM, Pavel M, Kidd M, Gustafsson BI. Review article: somatostatin analogs in the treatment of gastro-entero-pancreatic neuroendocrine (carcinoid) tumors. Alimentary Pharmacology & Therapeutics [Internet]. oct 2009 [cit\u00e9 7 juin 2022]; Disponible sur: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04174.x.","DOI":"10.1111\/j.1365-2036.2009.04174.x"},{"key":"10.1016\/j.revmed.2022.10.002_bib0175","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1\u00a0multicenter study","volume":"87","author":"Verg\u00e8s","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2022.10.002_bib0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","article-title":"Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database","volume":"58","author":"Giusti","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.revmed.2022.10.002_bib0185","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2022.10.002_bib0190","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.beem.2010.02.001","article-title":"Multiple endocrine neoplasia type 2","volume":"24","author":"Wohllk","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2022.10.002_bib0195","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/imj.14394","article-title":"Multiple endocrine neoplasia: an update","volume":"49","author":"McDonnell","year":"2019","journal-title":"Intern Med J"},{"key":"10.1016\/j.revmed.2022.10.002_bib0200","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/GIM.0b013e318216cc6d","article-title":"Multiple endocrine neoplasia type 2: an overview","volume":"13","author":"Moline","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.revmed.2022.10.002_bib0205","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1210\/er.2019-00007","article-title":"Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond","volume":"40","author":"Cabanillas","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.revmed.2022.10.002_bib0210","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of Selpercatinib in RET-Altered Thyroid Cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2022.10.002_bib0215","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0923-2532(02)01212-7","article-title":"Diagnostic biochimique des ph\u00e9ochromocytomes","volume":"17","author":"Corcuff","year":"2002","journal-title":"Immuno-analyse & Biologie Sp\u00e9cialis\u00e9e"},{"key":"10.1016\/j.revmed.2022.10.002_bib0110","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2214\/AJR.19.22542","article-title":"Multiple endocrine neoplasia: spectrum of abdominal manifestations","volume":"215","author":"Davila","year":"2020","journal-title":"AJR Am J Roentgenol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322006701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322006701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:46:19Z","timestamp":1759337179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866322006701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0248866322006701"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2022.10.002","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mise au point sur les n\u00e9oplasies endocriniennes multiples","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2022.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}